We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.79B
AUM Growth
+$493M
Cap. Flow
+$186M
Cap. Flow %
3.21%
Top 10 Hldgs %
23.53%
Holding
286
New
43
Increased
91
Reduced
94
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$52.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$43.8M
3
ABT icon
Abbott
ABT
+$37.3M
4
AMGN icon
Amgen
AMGN
+$35M
5
AME icon
Ametek
AME
+$28.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.2M
2
N
Netsuite Inc
N
+$40M
3
AGN
Allergan plc
AGN
+$39.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$38.9M
5
BCR
CR Bard Inc.
BCR
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 21.19%
3 Financials 20.46%
4 Communication Services 9.97%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSPN icon
126
OneSpan
OSPN
$562M
$13.6M 0.23%
771,991
+25,805
+3% +$454K
TEVA icon
127
Teva Pharmaceuticals
TEVA
$35.9B
$13.3M 0.23%
290,000
+72,433
+33% +$3.78M
CRTO icon
128
Criteo
CRTO
$1.03B
$13.3M 0.23%
379,224
+39
+0% +$1.54K
ELGX
129
DELISTED
Endologix Inc
ELGX
$13.2M 0.23%
102,900
+18,133
+21% +$2.32M
LAZ icon
130
Lazard
LAZ
$4.37B
$13M 0.22%
358,030
-17,470
-5% -$611K
AFL icon
131
Aflac
AFL
$63.9B
$12.9M 0.22%
360,000
+20,000
+6% +$728K
SPNT icon
132
SiriusPoint
SPNT
$2.98B
$12M 0.21%
1,000,000
+50,000
+5% +$622K
AXS icon
133
AXIS Capital
AXS
$8.59B
$12M 0.21%
220,000
– –
RLI icon
134
RLI Corp
RLI
$5.68B
$11.6M 0.2%
340,000
+15,000
+5% +$516K
SCHW
135
Charles Schwab
SCHW
$177B
$11.6M 0.2%
367,510
-13,873
-4% -$407K
AMED
136
DELISTED
Amedisys
AMED
$11.4M 0.2%
+240,600
New +$12M
AVGO icon
137
Broadcom
AVGO
$1.82T
$11.4M 0.2%
660,870
+190,950
+41% +$3.19M
MBLY
138
DELISTED
Mobileye N.V.
MBLY
$11.4M 0.2%
267,312
-23,471
-8% -$1.09M
SIMO icon
139
Silicon Motion
SIMO
$9.19B
$11.3M 0.2%
218,813
-74,150
-25% -$3.87M
HRTG icon
140
Heritage Insurance Holdings
HRTG
$842M
$10.4M 0.18%
720,000
+45,000
+7% +$592K
BLUE
141
DELISTED
bluebird bio
BLUE
$10.3M 0.18%
+11,787
New +$8.54M
RL icon
142
Ralph Lauren
RL
$22.2B
$10.2M 0.18%
101,010
-4,435
-4% -$445K
XLNX
143
DELISTED
Xilinx Inc
XLNX
$10.2M 0.18%
187,739
+97,765
+109% +$5.02M
MA icon
144
Mastercard
MA
$477B
$10.2M 0.18%
99,932
+32,992
+49% +$3.16M
HIMX
145
Himax Technologies
HIMX
$2.2B
$9.93M 0.17%
1,156,051
+118,700
+11% +$1.11M
PGR icon
146
Progressive
PGR
$124B
$9.61M 0.17%
305,000
+55,000
+22% +$1.79M
EBAY icon
147
eBay
EBAY
$48.6B
$8.95M 0.15%
272,011
-1,038,866
-79% -$31.4M
SLRC icon
148
SLR Investment Corp
SLRC
$706M
$8.36M 0.14%
407,500
– –
RNG icon
149
RingCentral
RNG
$4.05B
$8.22M 0.14%
347,794
+121,984
+54% +$2.76M
ARCC icon
150
Ares Capital
ARCC
$13.5B
$8.14M 0.14%
525,000
– –
4 5
6
7 8

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Polar Capital held 286 positions worth $5.79B, up 9.3% from $5.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $186M of net new capital in Q3 2016, opening 43 new positions and adding to 91 existing holdings. Its largest new stake was Canadian Natural Resources: 2,876,960 shares worth $52.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $66.2M trimmed.

  • Polar Capital's largest Q3 2016 buy was Canadian Natural Resources: 2,876,960 shares worth $52.7M.
  • Polar Capital added most to Merck in Q3 2016, an estimated $52.9M increase.
  • Polar Capital's biggest Q3 2016 reduction was Pfizer, cutting an estimated $66.2M.
  • Polar Capital fully exited Allergan plc in Q3 2016, selling an estimated $39.6M.
  • Polar Capital's ten largest holdings make up 24% of its $5.79B portfolio in Q3 2016.
  • Polar Capital opened 43 new positions and closed 31 in Q3 2016.
  • Polar Capital's portfolio value rose 9.3% quarter-over-quarter to $5.79B.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.